Naloxone is available as an intramuscular injection, intramuscular auto-injection, and nasal spray. The latter was approved ...
It's shockingly easy to get taxpayer funded drug kits courtesy of Public Health Seattle-King County. All you need to do is ...
Emergent launched 'Ready to Rescue' in partnership with NFL Hall of Famer Emmitt Smith after the approval of NARCAN® Nasal Spray to raise awareness and normalize preparedness, educate on the signs of ...
After the video training, participants were able to administer the single-step nasal spray naloxone with a higher rate of success than the intramuscular naloxone, and also to administer the single ...
Currently, intramuscular naloxone is publicly funded across Canada, but it can be stress-inducing and difficult for bystanders to administer naloxone through a syringe. Intranasal naloxone ...
Since the prescription launch of NARCAN® Nasal Spray in 2016, approximately 64 million doses have been distributed across the U.S. and Canada. In 2023, Emergent delivered approximately 11 million ...
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the shelf-life extension of Kloxxado (naloxone HCl) nasal spray 8mg from 24 to 36 months. Kloxxado packaging has ...
and how to safely recognize and respond to an opioid poisoning with Naloxone/Narcan Intramuscular and Intranasal kits. You can pick up a kit and will receive a training certificate from the Take Home ...
Emergent BioSolutions Inc. announced the introduction of a new NARCANDirect distribution centre in Nevada to further demonstrate its commitment to broadening access to NARCAN nasal spray nationwide.
LONDON, Aug. 15, 2024 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the shelf-life extension of KLOXXADO® (naloxone HCl) nasal spray 8mg ...
Customer-focused approach and continued investments in NARCAN ® Nasal Spray supply-readiness efforts help ensure opioid emergency preparedness GAITHERSBURG, Md., Aug. 06, 2024 (GLOBE NEWSWIRE) -- ...